DE2813017A1 - Neocarzinostatinderivate und verfahren zu ihrer herstellung - Google Patents

Neocarzinostatinderivate und verfahren zu ihrer herstellung

Info

Publication number
DE2813017A1
DE2813017A1 DE19782813017 DE2813017A DE2813017A1 DE 2813017 A1 DE2813017 A1 DE 2813017A1 DE 19782813017 DE19782813017 DE 19782813017 DE 2813017 A DE2813017 A DE 2813017A DE 2813017 A1 DE2813017 A1 DE 2813017A1
Authority
DE
Germany
Prior art keywords
residue
neocarcinostatin
fraction
polystyrene
maleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19782813017
Other languages
German (de)
English (en)
Other versions
DE2813017C2 (cg-RX-API-DMAC7.html
Inventor
Nakao Ishida
Ryunosuke Kanamaru
Hiroshi Maeda
Miyagi Sendai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maeda Hiroshi Kumamoto Jp Kuraray Co Ltd Ku
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE2813017A1 publication Critical patent/DE2813017A1/de
Application granted granted Critical
Publication of DE2813017C2 publication Critical patent/DE2813017C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/30—Introducing nitrogen atoms or nitrogen-containing groups
    • C08F8/32—Introducing nitrogen atoms or nitrogen-containing groups by reaction with amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/30—Introducing nitrogen atoms or nitrogen-containing groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S260/00—Chemistry of carbon compounds
    • Y10S260/47—Poisons, foods, or pharmaceuticals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
DE19782813017 1977-03-24 1978-03-23 Neocarzinostatinderivate und verfahren zu ihrer herstellung Granted DE2813017A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP52032412A JPS6017206B2 (ja) 1977-03-24 1977-03-24 ネオカルチノスタチン誘導体の製造法

Publications (2)

Publication Number Publication Date
DE2813017A1 true DE2813017A1 (de) 1978-10-05
DE2813017C2 DE2813017C2 (cg-RX-API-DMAC7.html) 1988-02-25

Family

ID=12358227

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19782813017 Granted DE2813017A1 (de) 1977-03-24 1978-03-23 Neocarzinostatinderivate und verfahren zu ihrer herstellung

Country Status (6)

Country Link
US (1) US4182752A (cg-RX-API-DMAC7.html)
JP (1) JPS6017206B2 (cg-RX-API-DMAC7.html)
CH (1) CH628637A5 (cg-RX-API-DMAC7.html)
DE (1) DE2813017A1 (cg-RX-API-DMAC7.html)
FR (1) FR2384811A1 (cg-RX-API-DMAC7.html)
GB (1) GB1565794A (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3367921D1 (en) * 1982-02-27 1987-01-15 Kuraray Co Neocarzinostatin complexes, a method for producing the same, and an antitumor agent containing said complexes as an active component
JPS58149903A (ja) * 1982-02-27 1983-09-06 Kuraray Co Ltd ネオカルチノスタチン複合体の製造法
JPS59139396A (ja) * 1983-01-31 1984-08-10 Kuraray Co Ltd ネオカルチノスタチン複合体の製造方法
US4604221A (en) * 1982-07-06 1986-08-05 The Lubrizol Corporation Nitrogen-containing esters and lubricants containing them
JPS6075432A (ja) * 1983-08-08 1985-04-27 Kuraray Co Ltd ネオカルチノスタチン誘導体及びその製造方法
JPS6075499A (ja) * 1983-08-08 1985-04-27 Kuraray Co Ltd ネオカルチノスタチン誘導体及びその製造法
US4594378A (en) * 1985-03-25 1986-06-10 The Lubrizol Corporation Polymeric compositions, oil compositions containing said polymeric compositions, transmission fluids and hydraulic fluids
JPS63211238A (ja) * 1987-02-27 1988-09-02 Masayasu Inoue 抗潰瘍剤
US5389366A (en) * 1986-09-19 1995-02-14 Yamanouchi Pharmaceutical Co., Ltd. Neocarzinostatin derivative composition for oral administration
JP2556865B2 (ja) * 1986-09-19 1996-11-27 山之内製薬株式会社 ネオカルチノスタチン誘導体の非注射投与用組成物
CA1327161C (en) * 1987-09-01 1994-02-22 Mitsugu Kobayashi Lyophilized pharmaceutical composition of neocarzinostatin derivative
US5001112A (en) * 1988-04-12 1991-03-19 Bristol-Myers Company Antitumor antibiotic kedarcidin
FR2688788B1 (fr) * 1992-03-17 1994-05-13 Bio Merieux Composes hydrosolubles derives d'un homopolymere ou copolymere de l'anhydride maleique, et applications desdits composes au support de molecules biologiques.
WO2001003738A1 (fr) * 1999-07-07 2001-01-18 Hiroshi Maeda Agents de type polymeres destines a la prevention de metastases et de la recurrence du cancer et methode de prevention de metastases et de la recurrence du cancer
GB0123232D0 (en) * 2001-09-26 2001-11-21 Smith & Nephew Polymers
JPWO2006112362A1 (ja) * 2005-04-18 2008-12-11 前田 浩 高分子型癌治療用医薬の製造方法
EP3072910A4 (en) * 2013-11-19 2018-02-21 Hiroshi Maeda Derivative of styrene-maleic acid copolymer

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3334022A (en) * 1965-04-26 1967-08-01 Room 605 Empire Corp Neocarzinostatin produced by streptomyces carzinost aticus var. neocarzinostaticus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3121043A (en) * 1960-05-11 1964-02-11 Scient Associates Inc Sustained release pharmaceutical preparation and methods for making same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3334022A (en) * 1965-04-26 1967-08-01 Room 605 Empire Corp Neocarzinostatin produced by streptomyces carzinost aticus var. neocarzinostaticus

Also Published As

Publication number Publication date
JPS6017206B2 (ja) 1985-05-01
DE2813017C2 (cg-RX-API-DMAC7.html) 1988-02-25
CH628637A5 (fr) 1982-03-15
US4182752A (en) 1980-01-08
GB1565794A (en) 1980-04-23
FR2384811A1 (fr) 1978-10-20
FR2384811B1 (cg-RX-API-DMAC7.html) 1982-11-19
JPS53117095A (en) 1978-10-13

Similar Documents

Publication Publication Date Title
DE2813017C2 (cg-RX-API-DMAC7.html)
DE3438296A1 (de) Neue polypeptide mit blutgerinnungshemmender wirkung, verfahren zu deren herstellung bzw. gewinnung, deren verwendung und diese enthaltende mittel
WO1980002560A1 (fr) Procede de prefabrication du polypeptide thymosine1 et de derives de celui-ci
DE19524515A1 (de) Saccharid-Konjugate
DE2647843A1 (de) Neue peptide, ihre herstellung sowie verfahren zur herstellung cyclischer peptide
DE69003595T2 (de) Mikroproteine, Verfahren zur Herstellung derselben und Anwendung dieser Mikroproteine als Arzneimittel.
DE3438455A1 (de) L-lysin- und l-histidinpyruvat
DE2634416A1 (de) Peptide, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2705514C3 (de) Nonapeptide und diese enthaltende Arzneimittel
EP0346501A1 (de) Arzneimittelzubereitung zur behandlung des immunmangels
DE3017372A1 (de) Physiologisch aktive polysaccharide, verfahren zu ihrer herstellung sowie ihre verwendung
EP0179332B1 (de) Neue ZNS-aktive Peptide mit Wirkung auf das cholinerge System
DE69217763T2 (de) Hexapeptide
DE2730549A1 (de) Peptidderivate und deren herstellung
DE2828933C3 (cg-RX-API-DMAC7.html)
EP0095557B1 (de) Polypeptide mit antagonistischen Eigenschaften gegenüber der Substanz P, Verfahren zu ihrer Herstellung, deren Verwendung und Verfahren zum Reinigen von Polypeptiden
EP0028716B1 (de) Motilitätssteigernde Peptide und deren Verwendung
DE1943207C3 (de) Tetrapeptidamide und Verfahren zu ihrer Herstellung
CH640510A5 (de) Verfahren zur herstellung und reinigung von sekretin.
DE2124451C3 (de) Peptide und ihre Verwendung bei der Bekämpfung von Hochdruck
DE69813137T2 (de) Pflanzenextrakt, verfahren zu dessen herstellung und seine verwendungen in der human- und tiermedizin
DE1767099B1 (de) Verfahren zur Gewinnung eines Glykoproteins mit einer Hemmwirkung gegenueber Magensaeureabsonderung und einer Antiaktivitaet gegenueber Ulcus-Bildung
DE1767099C (de) Verfahren zur Gewinnung eines Glykoproteins mit einer Hemmwirkung gegenüber Magensäureabsonderung und einer Antiaktivität gegenüber Ulcus-Bildung
DE2727048C2 (de) 8-Norleucyl-ceruletide
DE2243066C3 (de) Verfahren zur Herstellung von (Pyro) glutamyl-histWyl-tryptophyl-seryltyrosyl-glycyl-leucyl-arginyl-prolylglycinamid

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8127 New person/name/address of the applicant

Owner name: MAEDA, HIROSHI, KUMAMOTO, JP KURARAY CO., LTD., KU

8128 New person/name/address of the agent

Representative=s name: RIEDERER FRHR. VON PAAR ZU SCHOENAU, A., DIPL.-ING

8125 Change of the main classification

Ipc: C07K 17/08

8128 New person/name/address of the agent

Representative=s name: RIEDERER FRHR. VON PAAR ZU SCHOENAU, A., DIPL.-ING

8127 New person/name/address of the applicant

Owner name: MAEDA, HIROSHI, KUMAMOTO, JP KURARAY CO., LTD., KU

D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee